BackSoleno Therapeutics Overview

Soleno Therapeutics Other Liabilities

Track Soleno Therapeutics's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Soleno Therapeutics Other Liabilities History

Loading

Soleno Therapeutics vs. peers: Other Liabilities Comparison

Loading

Soleno Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Soleno Therapeutics (SLNO) FAQ

As of the most recent data (March 2026), SLNO shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLNO's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Soleno Therapeutics is outperforming or lagging.

Tracking SLNO's other liabilities over time shows whether Soleno Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Soleno Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Soleno Therapeutics's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.